Importance AGN-190584 (Allergan, an AbbVie company) is an optimized topical formulation
of pilocarpine hydrochloride, 1.25%, designed for managing presbyopia and enhanced with …

Pharmacological treatment of presbyopia may be an alternative for those who want a
spectacle-free scenario and an easy-to-use method with lower risk of irreversible ocular …

Purpose: To evaluate the effectiveness and safety of a new presbyopia-correcting
intraocular lens (IOL) with a nondiffractive design, DFT015, compared with an aspheric …

Presbyopia is the age-related loss of near-distance focusing ability. The aim of this study
was to identify patient-reported outcome measures (PROMs) used in clinical trials and …

Purpose: The purpose of this study was to evaluate the safety and efficacy across time, of
patients topically treated with Benozzi's method for presbyopia. Methods: A nonrandomized …

Vuity (pilocarpine HCL ophthalmic 1.25%) was approved for the treatment of presbyopia in
October 2021. Previous case series have reported the presence of vitreofoveal traction and …

Presbyopia reduces an individual's ability to perform visual tasks at near distances. It is a
global problem, affecting over a billion people worldwide. Contact lenses, glasses, refractive …

Introduction Refractive surgery in presbyopia tends to achieve spectacle independence with
minimal optical disturbances. We compared monovision to multifocality procedures …

Presbyopia affects 1.8 billion people worldwide. This reduction in distance corrected near
visual acuity impacts quality of life, which prompts patients to seek treatment. Presbyopia is …

Presbyopia occurs when the physiologically normal age-related reduction in the eyes
focusing range reaches a point, when optimally corrected for distance vision, that the clarity …